Biotech Analyst Watsek and Biopharma & Biotech Analysts Chen and Kim provide a review of ASH 2022 of emerging therapies for Hematologic Malignancies: AML, MDS, MM and CLL on an Analyst/Industry conference call to be held on December 14 at 11 am. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on KURA:
- Kura Oncology to Host Investor Event on December 10, 2022
- Kura Oncology to Participate in Two Upcoming Investor Conferences
- Kura Oncology Announces Four Abstracts Accepted for Presentation at ASH Annual Meeting
- Kura Oncology Reports Third Quarter 2022 Financial Results
- Kura Oncology to Report Third Quarter 2022 Financial Results
